Overview

Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis
Phase:
Phase 3
Details
Lead Sponsor:
Bayer